Download PDF

Other users also viewed these articles

P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST. Samael Rodríguez; Rebeca Rosas; Angel Omar Vazquez; Ivonne Palacios; Ricardo De la Rosa; Rebeca Escutia; Josep Jiménez; Luis Felipe Jave; Arturo Santos; Ana Sandoval; Juan Armendariz;
Ann Hepatol. 2024;29 Supl 1:
P- 39 N-ACETYL CYSTEINE ATTENUATES ALTERATIONS GENERATED IN EXPERIMENTAL LIVER STEATOSIS INDUCED BY CHRONIC ALCOHOL CONSUMPTION PLUS A HYPERCALORIC DIET Marina Galicia; Katia Berenice Roa; Angel Omar Vazquez; Hugo Christian Monroy; Rebeca Rosas; Ana Soledad Sandoval; Juan Armendariz;
Ann Hepatol. 2024;29 Supl 1:
P-21 FIBROSIS DEVELOPMENT AND MALIGNANCIES ARE DELAYED BY PIRFENIDONE WHILE INCREASING SIRT1 NUCLEAR TRANSLOCATION AND HISTONE 3 DEACETYLATIONS IN A HEPATOCARCINOMA MODEL Hugo Christian Monroy; Scarlet Arceo; Araceli Guadalupe Cabral; Marina Galicia; Juan Armendariz;
Ann Hepatol. 2024;29 Supl 1: